Cardica files for FDA clearance for MicroCutter device

August 16, 2013 by Sony Salzman

Cardica files for 510(k) clearance from the FDA for its MicroCutter Xchange 30 surgical stapling and cutting device.

Cardica hands in pre-market application for MicroCutter

Redwood City, Calif.-based Cardica (NSDQ:CRDC) said it filed for 510(k) clearance from the FDA for its surgical device.

Cardica said it filed all paperwork for a 510(k) for its MicrroCutter Xchange 30, which is already on the shelves in Europe. The U.S. is the largest market for surgical staplers world wide, according to the company.

Sign up to get our free newsletters delivered right to your inbox.

The FDA will review supporting evidence for the MicroCutter based on a recently completed European trial, which only reported 1 device-related adverse events out of 160 patients who went under the knife with MicroCutter.

MicroCutter is designed to reduce complications and post-operative pain from laparoscopic surgery. It has a much smaller cross-sectional area than typical surgical staplers, and can articulate 80 degrees, according to Cardica.

The company promised to submit the U.S. application after submitting a cartridge design validation application to Japan's Pharmaceuticals & Medical Devices Agency August 13.